Answer
Yes, for suitable patients using a licensed subcutaneous product after assessment, supervised first administration and injection training.
Sources for this answer
- Avtozma 162mg pre-filled pen — Current selected SmPCemc · Summary of Product Characteristics
- RoActemra 162 mg Solution for Injection in Pre-Filled Syringe — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.